Recommended reading

Team oriented problem solving via 8D

An 8D approach is a problem solving tool from the LEAN tool box (www.lean.org). It is a tool that you can use when you encounter a problem. It is a structured approach that analysis the problem, focuses on the origin of the problem by determining the root cause and established permanent corrective actions. It is an effective method to stop complex recurring problems without a real root cause from happening again.
You can find a document to help you perform this 8D here. You can find a general introduction on the root cause analysis and 8D in the presentation of Stephanie Herring here.

 


Risk management via FMEA

Failure Mode and Effects analysis is a methodology to perform a thorough risk assessment. This methodologies allows your organization to anticipate failures by identifying all the possible failures that could happen in a process.
FMEA is a structured approach to discover potential failures that may exist of could occur.
You can find a published example of FMEA here and a presentation on how to perform an FMEA by Alessandra Alteri here
If you want to start with FMEA in your organization, look at the non-conformity list. Detect the processes where the most failures occur and go through an FMEA for these processes. 
It is important to do this in a team exercise.

Read more about FMEA and ART on PubMed >


Guide on safety and quality of tissues and cells

The 4th guide on safety and quality of tissues and cells, including ART, is now freely downloadable from: https://register.edqm.eu/freepub.
You just need to fill in your e-mail address and you can download very interesting documents under the subheading ‘organs, tissues and cells’. You will have the possibility to download not only the 4th edition of the guide to quality and safety of tissues and cells for human application, but also other documents constructed by the council of Europe. The guide to quality and safety of tissues and cells for human application, is an elaborate document that includes recommendations that are considered to be ‘the minimum standards’ that align the principles set out in the various relevant European Union (EU) Directives. The document is the result of exceptional combined efforts and extensive discussions where ESHRE was part of.

Interested? Download the book and take a look!
In order to find the Guide, you have to look under the heading 'organs, tissues and cells'. There you will find the Guide on safety and quality of tissues and cells. If you tick this box, the EU will send you an email where you can download the whole book for FREE!

 


Guide and tool to perform risk assessment of novelties in your laboratory or center

EuroGTP II intended to provide practical tools which will assist Tissue Establishments and Organisations Responsible for Human Application, in the implementation of technical requirements defined for the assessment and verification of the quality, safety and efficacy of therapies with human T&C. Moreover, these tools are developed in accordance with the regulatory principles, legislation and good practices, and is made available to National Competent Authorities (NCAs), hence facilitating also the evaluation and the authorisation procedures. You get information on this risk assessment by accessing the website: http://www.goodtissuepractices.eu/
On the left side, you can find the guide explaining the risk tool and the link to the online free accessible interactive tool.



The Vienna consensus meeting: development of performance indicators for ART laboratory

This proceedings report presents the outcomes from an international workshop supported by the European Society of Human Reproduction and Embryology (ESHRE) and Alpha Scientists in Reproductive Medicine, designed to establish consensus on definitions and recommended values for Indicators for the assisted reproductive technology (ART) laboratory. Minimum performance-level values (‘competency’) and aspirational (‘benchmark’) values were recommended for a total of 19 Indicators, including 12 Key Performance Indicators (KPIs), five Performance Indicators (PIs), and two Reference Indicators (RIs).

Interested? Download the manuscript and take a look! [free download]
 



 Guidelines published by ESHRE

 

and more >

 


 

National guidelines

Our links point to existing guidelines in their original languages.


Belgium

No uniform national guidelines  Legislative website containing law on IVF


Bulgaria


Denmark

Guidelines


Finland

Act on Assisted Fertility Treatments


France

The Agence de Biomedicine (ABM) releases recommendations for all areas of medicine, including assisted reproductive technologies, Zika virus, tissue banking and genetics. Read here >


Hungary

Guidelines


Italy


The Netherlands

National guidelines - please select subheadings "richtlijnen" and "voortplantingsgeneeskunde".


Poland

Short version of the standards in infertility treatment published by Polish Gynecological Society and Polish Society of Reproductive Medicine and Embryology (PTMRiE) Current legal regulations

 

Switzerland

New law on medically assisted reproduction


United Kingdom


European Union


Recommended reading


Article not to be missed:
When and how should new technology be introduced into the IVF laboratory?
Harper J, Magli MC, Lundin K, Barratt CL, Brison D.
Hum Reprod. 2012 Feb;27(2):303-13 



Other documents

  • Proposal of guidelines for the appraisal of SEMen QUAlity studies (SEMQUA)
  • The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting
  • Risks and complications in assisted reproduction techniques: Report of an ESHRE consensus meeting
  • Laboratory guidelines for molecular diagnosis of Y-chromosomal microdeletions
  • Cochrane Gynaecology and Fertility Group (http://cgf.cochrane.org)